MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate?
Michael BaboudjianQuentin BandelierBastien Gondran-TellierRony AbdallahFloriane MichelPierre Clement SichezEugenie Di-CroccoAkram AkikiSarah GailletVeronique DelaporteMarc AndreLaurent DanielGilles KarsentyEric LechevallierRomain BoissierPublished in: International urology and nephrology (2019)
Introducing systematical MRI-targeted biopsy in our clinical setting increased the PCa DR without overdiagnosing insignPCa. Implementation of prebiopsy MRI does not seem to avoid the need for systematic biopsy, and nonsuspicious MRI should not obviate the need for prostate biopsy when otherwise clinically indicated.
Keyphrases
- prostate cancer
- contrast enhanced
- magnetic resonance imaging
- ultrasound guided
- fine needle aspiration
- radical prostatectomy
- diffusion weighted imaging
- healthcare
- primary care
- cancer therapy
- magnetic resonance
- drug delivery
- quality improvement
- real time pcr
- benign prostatic hyperplasia
- loop mediated isothermal amplification